After a few years of false starts, a third movie is in early development, with director Will Packer also looking to make a ...
After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use.
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18 executive order calling to speed up access to ...
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of ...
Psychedelic therapy shows promise, but what makes its effects last? The answer may lie not in the drug, but in what happens ...
Psychedelic therapy shows promise, but what makes its effects last? The answer may lie not in the drug, but in what happens ...
Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...
Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...
College Station Council Approves Rezoning For A New Housing Development Over Neighborhood Opposition
The College Station city council joins the planning and zoning commission (P&Z) in unanimously approving rezoning land for a large housing development that drew vocal opposition from neighboring ...
In an executive order issued last weekend, President Donald J. Trump directed the US Food and Drug Administration and the ...
Prausnitz, a Regents’ Professor, Regents’ Entrepreneur, and J. Erskine Love Jr. Chair in the School of Chemical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results